Published by Frank Prenesti on 11th November 2022
(Sharecast News) - AstraZeneca on Friday said its Imfinzi drug in combination with the Imjudo antibody and platinum-based chemotherapy has been approved in the US for the treatment of adult patients with stage IV non-small cell lung cancer.
URL: http://www.digitallook.com/dl/news/story/33102478/...